Is SUPN stock safe? | Glauxie AI

Q: Is SUPN stock safe?

Supernus Pharmaceuticals, Inc. (SUPN) operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector). The company is led by CEO Jack A. Khattar. Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United... Employees: 778.

Q: What are the risks of investing in SUPN?

Identify key risks of investing in SUPN — debt, competition, volatility, and sector headwinds.

Q: Is SUPN a good long-term investment?

Evaluate SUPN as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does SUPN have?

Review SUPN total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is SUPN stock safe?

🦉

Supernus Pharmaceuticals, Inc. (SUPN)

Company Overview

Sector / IndustryHealthcare / Drug Manufacturers - Specialty & Generic

CEOJack A. Khattar

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for...

Key Executives

Name	Title
Bryan A. Roecklein	Senior VP & Chief Business Officer
Frank Mottola	Senior Vice President & Chief Technology Operations Officer
Jack A. Khattar	Founder, President, Chief Executive Officer, Secretary & Director
Jeff Bozick	Senior Vice President of Supply Chain
Jonathan Rubin	Senior Vice President of Research & Development and Chief Medical Officer
Kevin T. Anderson	Compliance Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

SUPN Profile Financials

What are the risks of investing in SUPN? Is SUPN a good long-term investment? How much debt does SUPN have?